Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases" [Vaccine 42 (12) (2024) 3039-3048].
Schultze A, Martin I, Messina D, Bots S, Belitser S, Carreras-Martínez JJ, Correcher-Martinez E, Urchueguía-Fornes A, Martín-Pérez M, García-Poza P, Villalobos F, Pallejà-Millán M, Bissacco CA, Segundo E, Souverein P, Riefolo F, Durán CE, Gini R, Sturkenboom M, Klungel O, Douglas I. Schultze A, et al. Among authors: bissacco ca. Vaccine. 2025 Jan 12;44:126438. doi: 10.1016/j.vaccine.2024.126438. Epub 2024 Oct 13. Vaccine. 2025. PMID: 39396886 Free article. No abstract available.
Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example.
Bots SH, Belitser S, Groenwold RHH, Durán CE, Riera-Arnau J, Schultze A, Messina D, Segundo E, Douglas I, Carreras JJ, Garcia-Poza P, Gini R, Huerta C, Martín-Pérez M, Martin I, Paoletti O, Bissacco CA, Correcher-Martínez E, Souverein P, Urchuequía A, Villalobos F, Sturkenboom MCJM, Klungel OH. Bots SH, et al. Among authors: bissacco ca. Am J Epidemiol. 2024 Jul 3:kwae172. doi: 10.1093/aje/kwae172. Online ahead of print. Am J Epidemiol. 2024. PMID: 38960670
Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries.
Riefolo F, Castillo-Cano B, Martín-Pérez M, Messina D, Elbers R, Brink-Kwakkel D, Villalobos F, Ingrasciotta Y, Garcia-Poza P, Swart-Polinder K, Souverein P, Saiz LC, Bissacco CA, Leache L, Tari M, Crisafulli S, Grimaldi L, Vaz T, Gini R, Klungel O, Martín-Merino E. Riefolo F, et al. Among authors: bissacco ca. Vaccine. 2023 Nov 13;41(47):7007-7018. doi: 10.1016/j.vaccine.2023.10.011. Epub 2023 Oct 17. Vaccine. 2023. PMID: 37858451 Free article.